Having nearly completed my PGY2 in Emergency Medicine, I realize while my knowledge of topics pertinent to EM have made quantum leaps throughout the year - I had not realized how my knowledge in other areas had dwindled so rapidly. I consider my 'system' of keeping up with the literature to be sufficient (
previous blog post link) and, in general, Emergency Medicine covers a breadth of clinical topics compared to other specialties. I have begun to realize what my preceptors had warned me about just a few years prior... New drugs keep coming onto the market. My epiphany occurred when discussing a patient admitted for hypoglycemia who was prescribed a plethora of oral anti-hyperglycemic medications. The EM intern asked about the drugs on the list and how they worked. A fairly simple task that I felt adequately prepared to handle; that is until I happened upon "#@^&$gliflozin". Took a quick peak in my mobile drug reference and glanced at the medication class "SGLT2 Inhibitor". Perplexed look ensued.
What I love about my Emergency Medicine residency is how often this year I have said "I don't know". This was another instance of countless episodes of the show affectionately referred to by members of the ED staff as, "Cole Doesn't Know Now, But He Will Know Soon" (followed by
and then he will talk way too much about it for the next 20 minutes). This highlights the usefulness of programs like BPS Recertification through ASHP; I simply do not have time to stay abreast of ALL the literature that may be pertinent to my practice site at SOME point in the next 15 years. But with the ASHP BPS recert program, I am well equipped to stay up-to-date with quality information from high level practitioners. Now its time to learn more about
"#@^&$gliflozin"